Characterization of fosfomycin resistance and molecular epidemiology among carbapenem-resistant Klebsiella pneumoniae strains from two tertiary hospitals in China

Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP...

Full description

Saved in:
Bibliographic Details
Published inBMC microbiology Vol. 21; no. 1; pp. 109 - 8
Main Authors Wang, Haichen, Min, Changhang, Li, Jun, Yu, Ting, Hu, Yongmei, Dou, Qingya, Zou, Mingxiang
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 11.04.2021
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination. A total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (bla ), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation. Although the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed.
AbstractList Background Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination. Results A total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (bla.sub.KPC-2), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation. Conclusions Although the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed. Keywords: Carbapenem resistance, Klebsiella pneumoniae, Fosfomycin, fosA3
Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination. A total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (bla.sub.KPC-2), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation. Although the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed.
Abstract Background Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination. Results A total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (bla KPC-2), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation. Conclusions Although the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed.
Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination. A total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (bla ), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation. Although the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed.
Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination.BACKGROUNDFosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination.A total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (blaKPC-2), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation.RESULTSA total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (blaKPC-2), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation.Although the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed.CONCLUSIONSAlthough the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed.
Background Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella pneumoniae (CRKP). However, fosfomycin resistant cases has been reported gradually. In this study, we reported the fosfomycin-resistant rate in CRKP strains and further revealed the molecular mechanisms in resistance gene dissemination. Results A total of 294 non-duplicated CRKP strains were collected. And 55 fosfomyin-resistant strains were detected, 94.5% of which were clustered to sequence type (ST) 11 by PCR followed up sequencing. PFGE further revealed two major groups and four singletons. The positive rates of genes responsible to fosfomycin and carbapenem resistance were 81.8% (fosA3), 12.7% (fosA5) and 94.5% (blaKPC-2), respectively. Genomic analysis confirmed insertion sequence (IS) 26 was the predominant structure surrounding fosA3. The fosA3 genes in six isolates were located on plasmids which were able to transfer to E. coli J53 recipient cells by means of conjugation. Conclusions Although the resistant rate of CRKP to fosfomycin is relatively low in our area, considering its gene is located on transferrable plasmid and inserted in IS structure, continuous monitoring is still needed.
ArticleNumber 109
Audience Academic
Author Li, Jun
Zou, Mingxiang
Min, Changhang
Wang, Haichen
Dou, Qingya
Yu, Ting
Hu, Yongmei
Author_xml – sequence: 1
  givenname: Haichen
  surname: Wang
  fullname: Wang, Haichen
– sequence: 2
  givenname: Changhang
  surname: Min
  fullname: Min, Changhang
– sequence: 3
  givenname: Jun
  surname: Li
  fullname: Li, Jun
– sequence: 4
  givenname: Ting
  surname: Yu
  fullname: Yu, Ting
– sequence: 5
  givenname: Yongmei
  surname: Hu
  fullname: Hu, Yongmei
– sequence: 6
  givenname: Qingya
  surname: Dou
  fullname: Dou, Qingya
– sequence: 7
  givenname: Mingxiang
  surname: Zou
  fullname: Zou, Mingxiang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33838639$$D View this record in MEDLINE/PubMed
BookMark eNp9ktlu1DAUhiNURBd4AS6QJW7gIsXbeLlBqkYsIyohsVxbJ44z4yqxBzsByuPwpDidtnQqhKIojvP9_zk--Y-rgxCDq6qnBJ8SosSrTKgSosaUzLdY1PJBdUS4JDUlCh_cWR9WxzlfYEykYvJRdciYYkowfVT9Xm4ggR1d8r9g9DGg2KEu5i4Ol9YHlFz2eYRgHYLQoiH2zk49JOS2vnWDj31cXyIYYlgjC6mBrQtuqG9kI_rQuyZ71_eAtsFNBfTgUB4T-JBRl-KAxh8RlQZGD-kSbWLe-hH6jEr15cYHeFw97Mq7e3L9PKm-vn3zZfm-Pv_4brU8O6_tQsux1g3ljOCFZtYBA67JAlTHXMudYFh2TFMKCgtLMFMcJAVooRHENoI3srXspFrtfNsIF2ab_FD6MRG8udqIaW2gNGl7ZzpJG9tK4haWc65b0FxroltlsYNSuHi93nltp2ZwrXWhHLjfM93_EvzGrON3ozCTStNi8OLaIMVvk8ujGXy28xiDi1M2dFEioDkVrKDP76EXcUqhjGqmOJVCYPqXWkM5gA9dLHXtbGrOhCBMEcp5oU7_QZVr_te2xK_zZX9P8HJPUJjR_RzXMOVsVp8_7bPP7g7ldho3aSwA3QE2xZyT624Rgs0cebOLvClxN1eRN7KI1D2RLfmZozxnrP-f9A9jAAfM
CitedBy_id crossref_primary_10_1016_j_micres_2024_127701
crossref_primary_10_3389_fcimb_2024_1447933
crossref_primary_10_3390_ph15081011
crossref_primary_10_1186_s12941_023_00560_8
crossref_primary_10_1016_j_scitotenv_2022_153928
crossref_primary_10_1016_j_micpath_2025_107399
crossref_primary_10_1016_j_idairyj_2024_106068
crossref_primary_10_1136_archdischild_2021_322483
crossref_primary_10_1155_2022_2615753
crossref_primary_10_1016_j_micpath_2024_106728
crossref_primary_10_1016_j_scitotenv_2021_149859
crossref_primary_10_1128_spectrum_00095_23
Cites_doi 10.1016/j.ijantimicag.2016.02.001
10.1128/AAC.01834-09
10.1093/jac/dkq347
10.1016/j.ijantimicag.2009.11.011
10.1089/fpd.2016.2230
10.1016/j.ijantimicag.2020.106226
10.1016/j.ijantimicag.2016.08.013
10.1128/AAC.03061-14
10.1186/s12941-016-0148-y
10.1128/AAC.06122-11
10.1093/cid/ciq257
10.2147/IDR.S209877
10.1093/jac/dks192
10.1111/j.1469-0691.2011.03636.x
10.1099/jmm.0.000874
10.1016/j.diagmicrobio.2010.12.002
10.1089/mdr.2018.0137
10.1110/ps.03585004
10.1128/AAC.00734-08
10.1128/AAC.05104-11
10.1016/j.bpj.2018.12.002
10.1016/j.mimet.2005.03.018
10.1016/j.ijantimicag.2014.08.010
10.4103/0366-6999.189049
10.1016/j.jgar.2019.12.019
10.2147/IJGM.S214305
10.1099/jmm.0.000399
10.1099/jmm.0.062653-0
10.1093/jac/dkr466
ContentType Journal Article
Copyright COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID AAYXX
CITATION
NPM
ISR
3V.
7QL
7T7
7U9
7X7
7XB
88E
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7N
M7P
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s12866-021-02165-7
DatabaseName CrossRef
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList



PubMed
MEDLINE - Academic
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ: Directory of Open Access Journal (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
Statistics
EISSN 1471-2180
EndPage 8
ExternalDocumentID oai_doaj_org_article_f72bcd71e5c4449da949919d8c0ea915
PMC8037892
A661381244
33838639
10_1186_s12866_021_02165_7
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
7X7
88E
8FE
8FH
8FI
8FJ
A8Z
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ISR
ITC
KQ8
LK5
LK8
M1P
M48
M7P
M7R
MM.
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
~02
-A0
3V.
ACRMQ
ADINQ
AGJBV
C24
NPM
PMFND
7QL
7T7
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c597t-9b24310593cea3a4915a8f3ed4e6307f3922a806c10384a72aadab61cb64b7dc3
IEDL.DBID DOA
ISSN 1471-2180
IngestDate Wed Aug 27 01:30:06 EDT 2025
Thu Aug 21 14:12:04 EDT 2025
Fri Jul 11 04:15:35 EDT 2025
Fri Jul 25 19:15:15 EDT 2025
Tue Jun 17 21:08:17 EDT 2025
Tue Jun 10 20:28:03 EDT 2025
Fri Jun 27 05:00:01 EDT 2025
Wed Feb 19 02:27:54 EST 2025
Thu Apr 24 23:09:25 EDT 2025
Tue Jul 01 04:31:36 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Carbapenem resistance
fosA3
Klebsiella pneumoniae
Fosfomycin
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c597t-9b24310593cea3a4915a8f3ed4e6307f3922a806c10384a72aadab61cb64b7dc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/f72bcd71e5c4449da949919d8c0ea915
PMID 33838639
PQID 2514276602
PQPubID 42585
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_f72bcd71e5c4449da949919d8c0ea915
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8037892
proquest_miscellaneous_2511894263
proquest_journals_2514276602
gale_infotracmisc_A661381244
gale_infotracacademiconefile_A661381244
gale_incontextgauss_ISR_A661381244
pubmed_primary_33838639
crossref_primary_10_1186_s12866_021_02165_7
crossref_citationtrail_10_1186_s12866_021_02165_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-04-11
PublicationDateYYYYMMDD 2021-04-11
PublicationDate_xml – month: 04
  year: 2021
  text: 2021-04-11
  day: 11
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC microbiology
PublicationTitleAlternate BMC Microbiol
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References CR Lee (2165_CR21) 2016; 7
2165_CR22
DE Karageorgopoulos (2165_CR3) 2012; 67
S Takahata (2165_CR8) 2010; 35
PL Ho (2165_CR24) 2013; 62
R Raz (2165_CR2) 2012; 18
J Li (2165_CR27) 2016; 15
Y Fu (2165_CR31) 2012; 67
J Reyes (2165_CR1) 2019; 12
DJ Wolter (2165_CR26) 2009; 53
K Gupta (2165_CR4) 2011; 52
S Pakhomova (2165_CR9) 2004; 13
W Jiang (2165_CR15) 2017; 14
G Li (2165_CR18) 2015; 59
J Li (2165_CR20) 2016; 129
L Poirel (2165_CR25) 2011; 70
L Huang (2165_CR13) 2021; 57
E Rios (2165_CR28) 2017; 66
KZ Vardakas (2165_CR5) 2016; 47
VK Golla (2165_CR7) 2019; 116
J Wachino (2165_CR14) 2010; 54
L Villa (2165_CR16) 2010; 65
A Carattoli (2165_CR30) 2005; 63
Y Jiang (2165_CR17) 2015; 45
A Couce (2165_CR6) 2012; 56
P Liu (2165_CR12) 2020; 22
M Aghamali (2165_CR10) 2019; 68
PL Lu (2165_CR19) 2016; 48
YM Zhong (2165_CR29) 2019; 12
J Hou (2165_CR23) 2012; 56
J Chen (2165_CR11) 2019; 25
References_xml – volume: 47
  start-page: 269
  issue: 4
  year: 2016
  ident: 2165_CR5
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2016.02.001
– volume: 54
  start-page: 3061
  issue: 7
  year: 2010
  ident: 2165_CR14
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.01834-09
– volume: 65
  start-page: 2518
  issue: 12
  year: 2010
  ident: 2165_CR16
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkq347
– volume: 35
  start-page: 333
  issue: 4
  year: 2010
  ident: 2165_CR8
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2009.11.011
– volume: 14
  start-page: 210
  issue: 4
  year: 2017
  ident: 2165_CR15
  publication-title: Foodborne Pathog Dis
  doi: 10.1089/fpd.2016.2230
– volume: 57
  start-page: 106226
  issue: 1
  year: 2021
  ident: 2165_CR13
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2020.106226
– volume: 48
  start-page: 564
  issue: 5
  year: 2016
  ident: 2165_CR19
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2016.08.013
– volume: 7
  start-page: 895
  year: 2016
  ident: 2165_CR21
  publication-title: Front Microbiol
– volume: 59
  start-page: 338
  issue: 1
  year: 2015
  ident: 2165_CR18
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.03061-14
– volume: 15
  start-page: 35
  issue: 1
  year: 2016
  ident: 2165_CR27
  publication-title: Ann Clin Microbiol Antimicrob
  doi: 10.1186/s12941-016-0148-y
– volume: 56
  start-page: 2767
  issue: 5
  year: 2012
  ident: 2165_CR6
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.06122-11
– volume: 52
  start-page: e103
  issue: 5
  year: 2011
  ident: 2165_CR4
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciq257
– volume: 12
  start-page: 2069
  year: 2019
  ident: 2165_CR29
  publication-title: Infect Drug Resist
  doi: 10.2147/IDR.S209877
– volume: 67
  start-page: 2114
  issue: 9
  year: 2012
  ident: 2165_CR31
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dks192
– volume: 18
  start-page: 4
  issue: 1
  year: 2012
  ident: 2165_CR2
  publication-title: Clin Microbiol Infect
  doi: 10.1111/j.1469-0691.2011.03636.x
– ident: 2165_CR22
– volume: 68
  start-page: 11
  issue: 1
  year: 2019
  ident: 2165_CR10
  publication-title: J Med Microbiol
  doi: 10.1099/jmm.0.000874
– volume: 70
  start-page: 119
  issue: 1
  year: 2011
  ident: 2165_CR25
  publication-title: Diagn Microbiol Infect Dis
  doi: 10.1016/j.diagmicrobio.2010.12.002
– volume: 25
  start-page: 251
  issue: 2
  year: 2019
  ident: 2165_CR11
  publication-title: Microb Drug Resist
  doi: 10.1089/mdr.2018.0137
– volume: 13
  start-page: 1260
  issue: 5
  year: 2004
  ident: 2165_CR9
  publication-title: Protein Sci
  doi: 10.1110/ps.03585004
– volume: 53
  start-page: 557
  issue: 2
  year: 2009
  ident: 2165_CR26
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.00734-08
– volume: 56
  start-page: 2135
  issue: 4
  year: 2012
  ident: 2165_CR23
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.05104-11
– volume: 116
  start-page: 258
  issue: 2
  year: 2019
  ident: 2165_CR7
  publication-title: Biophys J
  doi: 10.1016/j.bpj.2018.12.002
– volume: 63
  start-page: 219
  issue: 3
  year: 2005
  ident: 2165_CR30
  publication-title: J Microbiol Methods
  doi: 10.1016/j.mimet.2005.03.018
– volume: 45
  start-page: 66
  issue: 1
  year: 2015
  ident: 2165_CR17
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2014.08.010
– volume: 129
  start-page: 2033
  issue: 17
  year: 2016
  ident: 2165_CR20
  publication-title: Chin Med J
  doi: 10.4103/0366-6999.189049
– volume: 22
  start-page: 238
  year: 2020
  ident: 2165_CR12
  publication-title: J Glob Antimicrob Resist
  doi: 10.1016/j.jgar.2019.12.019
– volume: 12
  start-page: 437
  year: 2019
  ident: 2165_CR1
  publication-title: Int J Gen Med
  doi: 10.2147/IJGM.S214305
– volume: 66
  start-page: 169
  issue: 2
  year: 2017
  ident: 2165_CR28
  publication-title: J Med Microbiol
  doi: 10.1099/jmm.0.000399
– volume: 62
  start-page: 1707
  issue: Pt 11
  year: 2013
  ident: 2165_CR24
  publication-title: J Med Microbiol
  doi: 10.1099/jmm.0.062653-0
– volume: 67
  start-page: 255
  issue: 2
  year: 2012
  ident: 2165_CR3
  publication-title: J Antimicrob Chemother
  doi: 10.1093/jac/dkr466
SSID ssj0017837
Score 2.3704143
Snippet Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant Klebsiella...
Background Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant...
Abstract Background Fosfomycin has been proven to be a vital choice to treat infection caused by multidrug resistance bacteria, especially carbapenem-resistant...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 109
SubjectTerms Amino acids
Antibiotics
Bacterial infections
Binding sites
Biosynthesis
Carbapenem resistance
Conjugation
Drug resistance in microorganisms
Drug therapy
E coli
Enzymes
Epidemiology
fosA3
Fosfomycin
Genes
Genetic aspects
Genomic analysis
Identification and classification
Infections
Klebsiella
Klebsiella infections
Klebsiella pneumoniae
Molecular modelling
Multidrug resistance
Physiological aspects
Plasmids
Statistics
Strains (organisms)
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4t1AQQYhcUBRY8drJydUKqoCggNQaW_WxHHalbrJstkV2r_DL2XGebQRUg97WY-168zbmfmGsbc5Sk0pIYudTHWsQKg4h8THKCroDxPpAKg5-dt3fXqmvsxn8_7Cre3LKgebGAx12Ti6Iz9EP6yk0TqRH1a_Y5oaRW9X-xEat9kdgi6jki4zHxMuYTD7GhplMn3Yoi3WVHIr6KNnsZk4o4DZ_79lvuaapmWT1_zQyQN2vw8g-VHH8Yfslq8fsbvdSMndY_b3eERg7hoseVPxqsHYdLlzi5pjdk0RI7KaQ13y5TAdl_urUbE7HkYQcUfvIlZoDJfxsG3Dv176ol1QzRRf1X6LhAvwvA2jJlpO3Sp886fhVGqwgPWOX_SDSVqOvx6mdT9hZyeffh2fxv0chthhurGJ80JimEGz_5yHFFQuZpBVqS-V12giKgyxkNuJdgS2rsBIgBIKLVyhVWFKlz5le3VT-33GMRkXzkkpKgzdjPQA2gM1z85Al9rIiImBIdb1IOV0gEsbkpVM246JFhloAxOtidj7cc-qg-i4kfoj8XmkJHjt8EWzPre9ttrKyMKVRviZU0rlJRCEj8jLzCUe8PgRe0NSYglAo6YKnXPYtq39_POHPcKAJw1RU8Te9URVg2dw0Dc84JMgzK0J5cGEEjXcTZcHYbS9hWntlT5E7PW4TDtJAmrfbAONyHKC5I_Ys052x3PT1USG6hgxM5HqyYOZrtSLi4A_niWpyXL5_Oa_9YLdk0HVVCzEAdvbrLf-JQZwm-JV0NJ_FERGxA
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZKERIXxLuBggxC4oACseO1kwNCpaIqoHIAKvVmTRynXWk3KZtdwf4dfikzTrJtRMWJQy7rsSLPw57ZeL6PsRc5ek0pIYudTHWsQKg4h8TH6Cp4HibSAVBz8tEXfXisPp1MTrbYQHfUK7C9srQjPqnjxez1rx_rdxjwb0PAZ_pNi3uspqu0gh49ic01dh1PJkOBeqQuvioYrMaGxpkr540Op4Dh__dOfemoGl-jvHQuHdxmt_qEku91HnCHbfn6LrvRUUyu77Hf-xtE5q7hkjcVrxrMVedrN605VtuUQaLpOdQlnw9sudxfUMeueaAk4o6-TaB2_Dwepi3555kv2indoeLntV-h4BQ8bwP1RMupe4Uvfzacrh5MYbHmZz1RScvx7YG9-z47Pvjwff8w7nkZYoflxzLOC4lpB3EBOg8pqFxMIKtSXyqvccuoMOVC6yfaEfi6AiMBSii0cIVWhSld-oBt103tdxjH4lw4J6WoMJUz0gNoD9RMOwFdaiMjJgaDWNeDltMCZjYUL5m2nREtGtAGI1oTsVebOecdZMc_pd-TnTeSBLcdfmgWp7aPXlsZWbjSCD9xSqm8BIL0EXmZucQDLj9iz8lLLAFq1HRj5xRWbWs_fvtq9zABSkMWFbGXvVDV4Boc9A0QqAnC4BpJ7o4kMeLdeHhwRjsEjEWlKWm0TlBnzzbDNJM8oPbNKsiILCeI_og97Hx3s276qyLD8IyYGXn1SDHjkXp6FvDIsyQ1WS4f_Q9NPmY3ZQhIFQuxy7aXi5V_gmnfsngaYvkPecRXGw
  priority: 102
  providerName: Scholars Portal
Title Characterization of fosfomycin resistance and molecular epidemiology among carbapenem-resistant Klebsiella pneumoniae strains from two tertiary hospitals in China
URI https://www.ncbi.nlm.nih.gov/pubmed/33838639
https://www.proquest.com/docview/2514276602
https://www.proquest.com/docview/2511894263
https://pubmed.ncbi.nlm.nih.gov/PMC8037892
https://doaj.org/article/f72bcd71e5c4449da949919d8c0ea915
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fb9MwELdgCIkXxH_CRmUQEg8oWuK4dvK4TpsGaBMqTKp4sS6OwyqtSbW0mvp1-KTcOUlphAQvPDQP9VmJ787nu-Tud4y9y1BrCgFpaEWiQgmxDDOIXIiqgudhJCwAFSefX6izS_lpNp7ttPqinLAWHrhl3GGpRW4LHbuxlVJmBRCaSpwVqY0cZL68XOCZ1wdT3fcDjXFXXyKTqsMGrbCiZNuYfmoc6sEx5NH6_7TJO4fSMGFy5wQ6fcQedq4jP2of-TG746on7H7bTHLzlP083mIvt6WVvC55WaNXutjYecUxriZfEYXMoSr4ou-Ly93vJrEb7psPcUtfIZZoBhdhP23FP1-7vJlTthRfVm6NhHNwvPFNJhpOdSp8dVtzSjKYw82GX3UtSRqOd_d9up-xy9OTb8dnYdeBIbQYaKzCLBfoYFDXP-sgAYn8hrRMXCGdQuNQonOFco6UJZh1CVoAFJCr2OZK5rqwyXO2V9WVe8k4huGxtULEJTptWjgA5YDKZsegCqVFwOJeIMZ28OS0gGvjw5RUmVaIBgVovBCNDtiH7ZxlC87xV-oJyXlLScDa_g9UN9Opm_mXugXsLWmJIeiMinJzfsC6aczHr1NzhK5O4v2lgL3viMoa12ChK3VAThDa1oDyYECJe9sOh3tlNJ1taQwyTQqtVIQ8e7MdppmkAZWr154mTjMC4w_Yi1Z3t-umlxIpbsSA6YFWDxgzHKnmVx55PI0SnWbi1f_g5D57IPyGlGEcH7C91c3avUYHb5WP2F090yN2b3Jy8WU68jsbr-cyxet08v0X3LxT9Q
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGJwQviP8EBhgE4gFFix3XSR4Q2samlm4TGpu0N-M4zlZpTUrTaurX4QPwGblzkm4R0t720Jf4nMa58_2J7-5HyIcEpCbjOvYND6UvNBN-ogPrg6iAPQy40RqLkw8O5eBEfD_tn66Rv20tDKZVtjrRKeqsNPiNfBPssOCRlAH_Ov3tI2oUnq62EBq1WIzs8hJCturL8Bvw9yPne7vHOwO_QRXwDTjPcz9JORhNRLIzVodaJKyv4zy0mbASBD4HhwGePZAGW4cLHXGtM51KZlIp0igzIdz3DlkXIYQyPbK-vXv442h1bhFBvNeW5sRyswLtLzHJl-FP9v2oY_4cSsD_tuCaMewmal6zfHsPyYPGZaVbtYw9Imu2eEzu1iCWyyfkz86q53Nd0knLnOYleMOTpRkXFOJ59FFBuKguMjpp8XipvQKnXVIHekQNnn5MQf1O_HbanI4ubFqNMUuLTgu7AMKxtrRy4BYVxfoYOr8sKSY3jPVsSc8bKJSKwr87fPCn5ORWePSM9IqysC8IhfCfGcM5y8FZjLjVWlqN5bp9LTMZcY-wliHKNG3RcQEXyoVHsVQ1ExUwUDkmqsgjn1dzpnVTkBupt5HPK0ps6O0ulLMz1egHlUc8NVnEbN8IIZJMY9MglmSxCayG5XvkPUqJwpYdBeYEnelFVanhzyO1BS5W6Pw0j3xqiPIS1mB0U2IBbwK7fHUoNzqUoFNMd7gVRtXotEpd7UCPvFsN40yUgMKWC0fD4gRBADzyvJbd1brxY0gMCsAjUUeqOy-mO1KMz13H8zgIozjhL29-rLfk3uD4YF_tDw9Hr8h97rad8BnbIL35bGFfg_s4T980e5aSX7etJv4BtByEpw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+fosfomycin+resistance+and+molecular+epidemiology+among+carbapenem-resistant+Klebsiella+pneumoniae+strains+from+two+tertiary+hospitals+in+China&rft.jtitle=BMC+microbiology&rft.au=Haichen+Wang&rft.au=Changhang+Min&rft.au=Jun+Li&rft.au=Ting+Yu&rft.date=2021-04-11&rft.pub=BMC&rft.eissn=1471-2180&rft.volume=21&rft.issue=1&rft.spage=1&rft.epage=8&rft_id=info:doi/10.1186%2Fs12866-021-02165-7&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_f72bcd71e5c4449da949919d8c0ea915
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2180&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2180&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2180&client=summon